Ibumax

Ibuprofen, the active ingredient in Ibumax, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats mild to moderate pain, fever and inflammatory conditions such as arthritis in adults and children when appropriate. GNH USA supplies Ibumax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen, an NSAID, provides analgesic, antipyretic and anti‑inflammatory effects across several common conditions.

Mild to moderate pain: relief of headache, dental pain, musculoskeletal discomfort. Fever: reduction of elevated body temperature associated with infection or inflammation. Inflammatory conditions such as arthritis: decrease swelling and improve joint mobility.

Ibuprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Renal impairment or failure - Hepatotoxicity - Severe hypersensitivity reactions, including anaphylaxis - Cardiovascular events such as myocardial infarction - Severe skin reactions (e.g., Stevens‑Johnson syndrome)

When using Ibumax, consider the following precautions:

Assess renal function: monitor in patients with kidney disease. Evaluate cardiovascular risk: use cautiously in patients with heart disease. Avoid in known hypersensitivity: discontinue if allergic reaction occurs. Use with caution in pregnancy: limited data, discuss with healthcare provider. Consider drug interactions: review concomitant NSAIDs or anticoagulants. Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines; awareness helps minimize risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhage risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Methotrexate: decreased clearance leading to toxicity.